Dr. Guy Boivin is a medical microbiologist/virologist and an infectious disease specialist working at the "Québec City University Hospital Center" (CHU of Quebec-CHUL) in Canada. Dr. Boivin is also a professor of microbiology-immunology at Laval University and a senior researcher in virology at the "Research Center in Infectious Diseases" of the same University.
Dr. Boivin holds a MD from Laval University, a master (MSc) degree in microbiology from University of Montréal and a 3-year specialized research training (Fellowship) in Molecular Virology from University of Minnesota.
Dr. Boivin is currently the holder of the Canada Research Chair on Influenza Viruses and Other Respiratory Viruses (2006-13, renewed for 2013-20). His research is currently supported by a 7-year Foundation grant from the Canadian Institutes of Health Research (2016-23, $3,914,226) and by several contracts with private companies. His main research interests concern the diagnosis, pathogenesis, prevention and treatment of viral diseases caused by respiratory viruses (mainly influenza viruses, human metapneumovirus and human respiratory syncytial virus) and herpesviruses (mainly cytomegalovirus and herpes simplex virus) as well as the mechanisms of resistance to antiviral drugs.
Dr. Boivin is member of several distinguished societies including the American Society for Microbiology, the American Society of Transplantation, the Canadian Association of Medical Microbiology and Infectious Diseases, the Canadian Society for Clinical Investigation and the Quebec AIDS and Respiratory Diseases Networks.
Finally, Dr. Boivin has published more than 275 peer-reviewed manuscripts and presented more than 70 invited conferences and 260 communication abstracts since 1993. He was on the Editorial board of the Journal of Infectious Diseases, in which he has published more than 40 articles.